Treatment of Hypercholesterolemia With Ezetimibe in Cardiac Transplant Recipients

Journal of Heart and Lung Transplantation

Volumn 26, Issue 3, 2007, Pages 281-284

  Patel, Ayan R ^a   Ambrose, Marietta S ^a   Duffy, Gretchen A ^a   Cote, Heather ^a   DeNofrio, David ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CALCINEURIN INHIBITOR; CHOLESTEROL; CYCLOSPORIN; EZETIMIBE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; PRAVASTATIN; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; FEMALE; GUILLAIN BARRE SYNDROME; HEART GRAFT; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYALGIA; MYOSITIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; AZETIDINES; FEMALE; HEART TRANSPLANTATION; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MUSCULAR DISEASES; PAIN;

EID: 33847375619     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.01.008     Document Type: Article

References (16)

1. Kobashigawa J.A., Katnelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621-627
2. Wenke K., Meiser B., Thiery J., et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation. Circulation 96 (1997) 1398-1402
3. See V.Y., DeNofrio D., Goldberg L., et al. Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial function. Am J Cardiol 92 (2003) 11-15
4. Wenke K., Meiser B., Thiery J., et al. Simvastatin initiated early after heart transplantation: 8-year prospective experience. Circulation 107 (2003) 93-97
5. Bilchick K.C., Henrikson C.A., Skojee D., Kasper E.K., and Blumenthal R.S. Treatment of hyperlipidemia in cardiac transplant recipients. Am Heart J 148 (2004) 200-210
6. Lindenfeld J., Page R.L., Zolty R., et al. Drug therapy in the heart transplant recipient, Part III: The common medical problems. Circulation 111 (2005) 113-117
7. Bergman A.J., Burke J., Larson P., et al. Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients. J Clin Pharm 43 (2006) 328-336
8. Koshman S.L., Lalonde L.D., Burton J., Tymchak W.J., and Pearson G.J. Supratherapeutic response to ezetimibe administered with cyclosporine. Ann Pharmacother 31 (2005) 1561-1565
9. Kosoglou T., Statkevich P., Johnson Levonas A.J., Paolini J.F., Bergman A.J., and Alton K.B. Ezetimibe: a review of its metabolism, pharmacokinetics, and drug interactions. Clinical Pharmacokinetics 44 (2005) 467-497
10. Buchanan C., Smith L., Corbett J., Nelson E., and Shihab F. A retrospective analysis of ezetimibe treatment in renal transplant recipients. Am J Transplantation 6 (2006) 770-774
11. Kohnle M., Pietruck F., Kribben A., Philipp Th., Heemann U., and Witzke O. Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation. Am J Transplantation 6 (2006) 205-208
12. Langone A.K., and Chuang P. Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors. Transplantation 81 (2006) 804-807
13. Puthenparempil J.J., Keough-Ryan T., Kiberd M., Lowen J., and Kiberd B.A. Treatment of hypercholesterolemia with ezetimibe in the kidney transplant population. Transplantation Proceedings (2003) 1033-1035
14. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
15. Kobashigawa J. Statins in solid organ transplantation: is there an immunosuppressive effect?. Am J Transplantation 4 (2004) 1013-1018
16. Mazoa-Rivas R., Crespo-Leiro M.G., Paniagua-Marin M.G., et al. Safety of statins when response is carefully monitored: a study of 336 heart recipients. Transplantation Proceedings 37 (2005) 4071-4079